180 results
Page 2 of 9
8-K
EX-99.1
qx13 ubcu
17 Feb 22
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
7:49am
424B7
5km2fmwj2 66f7i9q5
5 Nov 21
Prospectus with selling stockholder info
4:16pm
8-K
EX-99.1
ic53i1h9byqtl8qhhl1e
28 Oct 21
Repligen Reports Third Quarter 2021 Financial Results
7:55am
8-K
EX-99.1
ker56h5fb
16 Sep 21
Proposed acquisition strengthens Repligen’s Proteins business
7:53am
8-K
EX-99.1
pxvmfkf14beq
27 Jul 21
Repligen Reports Second Quarter 2021 Financial Results
7:42am
DEFR14A
n7olw 15nmx5no
5 May 21
Revised proxy
4:16pm
8-K
EX-99.1
8ay6ege432utt66tc34
4 May 21
Repligen Reports First Quarter 2021 Financial Results
7:54am
8-K
EX-99.1
pan3qrc3a
24 Feb 21
Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
7:54am
8-K
EX-3.1
cpccfoo7ebwv mv
28 Jan 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-99.1
kw5d lp548llw
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
8-K
EX-99.2
hiqb44 f4v26mup
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
424B5
k9vq3ple5
8 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
2kchc ded
7 Dec 20
Prospectus supplement for primary offering
7:24am